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Stable expression of Foxp3 is ensured by demethylation of 
CpG motifs in the Foxp3 intronic element, the conserved 
non-coding sequence 2 (CNS2), which persists throughout 
the lifespan of regulatory T cells (Tregs). However, little is 
known about the mechanisms on how CNS2 demethyla-
tion is sustained. In this study, we found that Ten-Eleven-
Translocation (Tet) DNA dioxygenase protects the CpG 
motifs of CNS2 from re-methylation by DNA methyltrans-
ferases (Dnmts) and prevents Tregs from losing Foxp3 
expression under inflammatory conditions. Upon stimula-
tion of Tregs by interleukin-6 (IL6), Dnmt1 was recruited to 
CNS2 and induced methylation, which was inhibited by 
Tet2 recruited by IL2. Tet2 prevented CNS2 re-methylation 
by not only the occupancy of the CNS2 locus but also by 
its enzymatic activity. These results show that the CNS2 
methylation status is dynamically regulated by a balance 
between Tets and Dnmts which influences the expression 
of Foxp3 in Tregs. 
 
 
INTRODUCTION 
1 
Forkhead box P3+ (Foxp3+) CD4+ regulatory T cells (Tregs) 
control a variety of immune responses in a Foxp3 dependent 
manner (Fontenot et al., 2003; Hori et al., 2003). During these 
processes, Tregs differentiate functionally and adapt them-
selves to diverse environmental stimuli (Campbell and Koch, 
2011). For example, some Tregs co-express Foxp3 and other 
lineage or tissue specific transcription factors like T-bet, ROR-t, 
Bcl6 and PPAR- to control the corresponding immune and 
non-immune responses (Burzyn et al., 2013; Chaudhry et al., 
2009; Chung et al., 2011; Cipolletta et al., 2012; Koch et al., 
2009; Linterman et al., 2011; Ohnmacht et al., 2015; Sefik et al., 
2015; Wang et al., 2011). What is interesting is that some of the 
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lineage specifying transcription factors expressed together with 
Foxp3 like T-bet, GATA3, ROR-t and Bcl6 are induced by 
proinflammatory cytokines antagonizing Foxp3 expression. 
These reports suggest that unique mechanisms stabilizing the 
expression of Foxp3 should exist for Tregs to adapt to envi-
ronmental changes and to preserve their identity at the same 
time (Sakaguchi et al., 2013). 
Stable expression of Foxp3 is accompanied by epigenetic 
modulation of the CpG motifs within the evolutionarily con-
served non-coding sequence 2 (CNS2) enhancer of the Foxp3 
locus (Floess et al., 2007; Huehn and Beyer, 2015; Huehn et al., 
2009; Kim and Leonard, 2007). Demethylation of the CpG mo-
tifs in the CNS2 enhancer enables critical transcription factors 
like Foxp3 and Runx1-Cbf- complex to access the CNS2 en-
hancer region and the CNS2 enhancer itself to interact with the 
promoter through a loop structure, which, as a result, has cen-
tral roles in stabilizing Foxp3 expression especially under in-
flammatory conditions (Feng et al., 2014; Li et al., 2014; Zheng 
et al., 2010). Consistent with the above reports, CNS2 is de-
methylated in Tregs expressing Foxp3 stably but methylated in 
activated CD4+ T cells or TGF--induced Tregs expressing 
Foxp3 transiently (Miyao et al., 2012; Polansky et al., 2008). 
CNS2 demethylation occurs in the thymus or periphery 
through iterative DNA oxidation reactions done by Ten-Eleven-
Translocation (Tet) family members (Sasidharan Nair et al., 
2016; Toker et al., 2013; Yang et al., 2015; Yue et al., 2016) 
and is known to be maintained consistently once established 
(Miyao et al., 2012). Indeed, CNS2 demethylation, instead of 
Foxp3 expression, was reported to be used as a reliable meth-
od for counting Tregs in peripheral blood and solid tissue 
(Wieczorek et al., 2009). However, how CNS2 demethylation is 
maintained in Tregs has not been clearly elucidated yet. In this 
study, we addressed the question whether Tet proteins have a 
role in maintaining as well as generating CNS2 demethylation 
and found that Tet proteins recruited to the CNS2 locus by IL2 
protect the demethylated CpG motifs from being re-methylated 
by the occupancy of the CNS2 locus and its demethylase activi-
ty resulting in the stable expression of Foxp3 in Tregs. 
 
MATERIALS AND METHODS 
 
Mice 
Wild-type (WT) C57BL/6 (B6) mice were purchased from 
Koatech (Pyeongtaek, Gyeongi-do, Korea). CD45.1 congenic 
(B6.SJL-Ptprca Pepcb/BoyJ), Foxp3-GFP transgenic (Foxp3  
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bicistronic reporter mice expressing EGFP: B6.Cg-Foxp3tm2Tch/J), 
floxed Tet2 transgenic (B6;129S-Tet2tm1.1Iaai/J, Tet2fl/fl) (Moran-
Crusio et al., 2011) mice were obtained from The Jackson La-
boratory (Bar Harbor, ME). To generate Tet2 deficient mice 
(CD4-Cre  Tet2fl/fl, referred to as Tet2−/− mice), CD4-Cre trans-
genic mice were crossed to floxed Tet2 transgenic mice. The 
level of Tet2 expression was checked by RT-qPCR in CD4+ T 
cells and Tet2, but not Tet1 or Tet3, mRNA was greatly down-
regulated in CD4+ T cells in Tet2−/− mice (data not shown). In 
most cases, Tet2−/− mice were further crossed with YFP report-
er (floxed-STOP-YFP) mice (B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/ 
J, Jackson laboratory) for checking the activity of the Cre en-
zyme. Tet2fl/fl or CD4-Cre  Tet2+/+ mice were used as WT con-
trol. OT-II transgenic mice expressing OVA-specific TCR were 
bred to Tet2−/− mice to generate OT-II/Tet2−/− mice, which were 
used for the adoptive transfer followed by OVA/CFA immuniza-
tion experiments. Foxp3-GFP-Cre transgenic mice (NOD/ShiLt-
Tg(Foxp3-EGFP/cre)1cJbs/J, Jackson laboratory, referred to 
as Foxp3-Cre mice) were also crossed with floxed Tet2 trans-
genic mice to delete Tet2 specifically in Tregs. Since we were 
not confident how many times Foxp3-Cre mice were back-
crossed with B6 mice, Foxp3-Cre  Tet2fl/fl mice were consid-
ered in the mixed background (B6  NOD) and littermates were 
used as WT controls. Foxp3-Cre mice were used only in Figs. 
2B, 2C and Supplementary Fig. S2. Only male mice were cho-
sen in CNS2 demethylation analysis. All animal experimenta-
tions were conducted in accordance with guidelines and ap-
proval of the International Animal Care and Use Committees 
(IACUC) of Hallym University (Hallym 2014-74, 2015-63). 
 
Cell isolation and flow cytometry 
To sort naïve CD4+ cells and Treg cells, CD44, CD25 and YFP 
were used (naïve cells: CD4+CD8−CD44lowCD25−YFP+; Treg 
cells: CD4+CD8−CD25+YFP+). The post-sort purity for each cell 
type was usually > 95%. We purchased the following monoclo-
nal antibodies from BD Biosciences, eBioscience (USA) or 
BioLegend (USA) for flow cytometry: R-phycoerythrin (PE)-, 
PerCP-Cy5.5-, Allophycocyanin (APC)- or Brilliant Violet 421 
(BV421)-labeled anti-CD25 (clones PC61 and 7D4), PE-Cy7-, 
PerCP-Cy5.5- or APC- or BV421-labeled anti-CD4 (clones 
RM4-5 and GK1.5), Fluorescein isothiocyanate (FITC)-, PE- or 
PerCP-Cy5.5-labeled anti-CD44 (clone IM7), PerCP-Cy5.5- or 
APC-labeled anti-CD45.1 (clone A20), PE- , PE-Cy7-, PerCP-
Cy5.5- or Brilliant Violet 510 (BV510)-labeled-anti-CD45.2 
(clone 104), PE-labeled-anti-CD62L (clone MEL-14), PE-
labeled-anti-CD69 (clone H1.2F3), PerCP-Cy5.5- or APC- or 
APC-Cy7-labeled-anti-CD8 (clone 53-6.7), APC-labeled-anti-
CD86 (clone GL1), PE-labeled-anti-CTLA4 (clone UC10-4F10-
11), Alexa Fluor 488- or PE-labeled-anti-Foxp3 (clone FJK-16s), 
APC-labeled-anti-IFN- (clone XMG1.2), PE-labeled-IL17 
(clone TC11-18H10.1) unconjugated anti-Myc (9E10, Santa 
Cruz Biotechnology, Dallas, Texas) and APC-labeled-donkey 
anti-mouse IgG (Jackson immunoresearch, West Grove, PA). 
Intracellular Foxp3, cytokines, myc-tagged proteins were 
stained using Foxp3 Staining Buffer set (eBioscience). For 
cytokine analysis, cells were cultured for 4 hours in the pres-
ence of PMA/ionomycin plus monensin (BD biosciences) be-
fore intracellular cytokine staining. Data were acquired through 
FACS Calibur or FACS Canto-II (BD Biosciences) and were 
analyzed with FlowJo software (Tree Star, USA) (Kim et al., 
2015). 
 
Cell culture 
FACS-sorted cells were cultured in complete RPMI-1640 medi-
um (WelGENE, Korea), supplemented with 10% FBS (WelGENE), 
penicillin, streptomycin (Sigma-Aldrich, USA), L-glutamine (2 
mM; Life Technologies, USA), sodium pyruvate (2 mM; Sigma-
Aldrich), non essential amino acid (0.1 mM; Sigma-Aldrich) and 
2-ME (50 M; Sigma-Aldrich). For CD3/CD28 stimulation, 
FACS-sorted cells were stimulated by plate-bound anti-CD3 
(2C11, 1 g/ml; eBioscience) plus CD28 (37.51, 1 g/ml) in the 
presence or absence of recombinant murine IL2 (rIL2; Pepro-
tech, Rocky Hill, NJ, USA), recombinant IL6 (rIL6; Peprotech), 
recombinant IL4 (rIL4; Peprotech) or recombinant IL12 (rIL12; 
Peprotech) for indicated periods.  
 
Foxp3 demethylation analysis 
The genomic DNA was extracted from the FACS-sorted live 
cells by using the Blood & Tissue Genomic DNA Extraction kit 
(Qiagen, USA). For isolation of DNA from cells fixed and 
stained with anti-Foxp3 mAb, we used the protocol described 
previously (Hansmann et al., 2010; Piper et al., 2014). Briefly, 
sorted cells (CD4+CD8−Foxp3+CD25+) were incubated with 
300 l lysis buffer (10 mM Tris-HCl, 100 mM NaCl, 50 mM 
EDTA, 0.5% SDS, 0.1 g/ml proteinase K, and 20 g/ml 
RNase A) for 24 hours at 60°C. Then DNA was extracted by 
phenol/chloroform/isoamyl alcohol solution (25:24:1) and 
precipitated overnight by ethanol. Extracted genomic DNAs 
were converted by the EZ DNA methylation gold kit (Zymo 
Research, USA). Anti-sense (Ohkura et al., 2012) strands of 
bisulfite-treated DNA were then subjected to PCR for amplifi-
cation of CNS2 (12 CpG motifs were analyzed). The PCR 
products obtained were cloned into the pGemT-easy vector 
(Promega, USA) and 10-30 individual clones from each sam-
ple were sequenced with M13 reverse primer (GAAACAGCT 
ATGACCATG). 
 
Chromatin immunoprecipitation 
Nuclear lysate was sonicated to make small DNA fragments 
ranging from 100–500 base pairs and then incubated with anti-
Tet2 (ab94580, Abcam, UK) or anti-Dnmt1 Ab (H-300, Santa 
Cruz Biotechnology) overnight at 4°C. Isotype-matched control 
Ab was used for the negative control. Immune complexes con-
taining DNA fragments were precipitated using Dynabeads 
(Invitrogen, USA) or EZ-ChIP kit (Milipore, Germany). Relative 
enrichment of the target regions in the precipitated DNA frag-
ments was analyzed by qPCR. The sequences of primers are 
as follows. 
CNS2 forward, 5-AAC CTT GGG CCC CTC TGG CA-3 
CNS2 reverse, 5-GGC CGG ATG CAT TGG GCT TCA-3 
Foxp3 promoter forward, 5-CTT CTG GGA GCC AGC CAT-3 
Foxp3 promoter reverse, 5-GCT GTA CTC CCC CCA CAA 
ATT-3 
 
Quantitative RT-PCR (RT-qPCR) 
RNA was isolated from FACS-sorted cells using the RNeasy 
Mini kit (Qiagen) or Trizol (Life Technologies), and reverse-
transcribed into cDNA using QuantiTect Reverse Transcription 
kit (Qiagen). Quantitative PCR (qPCR) reactions were per-
formed on RotorGene 6000 system (Qiagen) using AccuPower 
GreenStar qPCR kit (Bioneer, Korea). All data were normalized 
to actin. Non-specific amplification was checked by the use of 
melting curve and agarose gel electorphoresis. The sequences 
of primers are as follows. 
Tet1 forward, 5-GAG CCT GTT CCT CGA TGT GG-3 
Tet1 reverse, 5-CAA ACC CAC CTG AGG CTG TT-3 
Tet2 forward, 5-AGA GCC TCA AGC AAC CAA AA-3 
Tet2 reverse, 5-ACA TCC CTG AGA GCT CTT GC-3 
Tet3 forward, 5-TCC GGA TTG AGA AGG TCA TC-3 
Tet3 reverse, 5-CCA GGC CAG GAT CAA GAT AA-3 
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Actin forward, 5-CAT CCG TAA AGA CCT CTA TGC CAA C-3 
Actin reverse, 5-ATG GAG CCA CCG ATC CAC A-3 
 
Transfection 
Plasmids transfection experiments were performed using 
FACS-sorted Tet2−/− Tregs. Cells were transfected with plas-
mids encoding Myc-tagged mouse Tet2 (wt or mutant) or emp-
ty vector by using the electroporation kit (Amaxa Nucleofector 
Kit and Nucleofector device, Lonza, USA). Transfected Tregs 
were cultured for 3 days under the indicated condition for CNS2 
demethylation study. Transfection efficiency and the expression 
levels were checked 4 hours after transfection by flow cytome-
try and RT-qPCR. 
 
Small interfering RNA transfection  
Transfection of Tregs was performed using the Mouse T Cell 
Nucleofector Kit and the Nucleofector device (X-001 program) 
according to the kit directions (Lonza). Cells were transfected 
with 300 pmol SMART pool siRNAs (Dharmacon, USA) de-
signed against mouse Tet1 (M-062861-01-0005) and mouse 
Tet3 (L-054156-01-0005), or non-targeting control siRNAs (SN-
1001, Bioneer). The expression levels of each Tet were 
checked 4 hours after electroporation by RT-PCR. (Mantei et 
al., 2008).  
 
In vitro Suppression Assay 
FACS-sorted naïve CD4+ T cells labeled with cell trace violet 
(cell division dye, Life Technologies) were used as responders. 
Antigen presenting cells were prepared by depleting CD4+ and 
CD8+ cells from wild-type B6 splenocytes using flow cytometry. 
Responder cells (5  103) were cultured with antigen presenting 
cells (2  104) and soluble anti-CD3 mAb (0.3 g/ml) in the 
absence or presence of various numbers of Treg cells for 3 
days. The division of responder cells was assessed by dilution 
of cell trace violet. 
 
Adoptive transfer and immunization experiments 
FACS-sorted OT-II Tregs were injected intravenously into con-
genic WT B6 mice. The next day, the recipient mice were sub-
cutaneously immunized in the left flank with 100g of OVA in 
CFA (Sigma-Aldrich) and injected intraperitoneally with sulfinpy-
razone (10 g/g body weight) or vehicle (DMSO) every day. In 
7 days OT-II CD4+Foxp3+ Tregs of donor origin were FACS-
sorted from the draining left axillary LNs and subjected to CNS2 
demethylation study. In some cases, the recipient mice were 
treated with congenically marked OT-II naïve and Treg cells 
together with anti-IL2 mAb. 
 
Statistical analyses 
A two-tailed, unpaired, student’s t-test was used to calculate the 
statistical significance of differences between two groups un-
less specified. P values were represented as follows: ***, P < 
0.001; **, P < 0.01; *, P < 0.05, whereas NS (not significant) 
was used to denote P values > 0.05. Error bars indicate s.e.m. 
ND means ‘not detected’. 
 
RESULTS AND DISCUSSION  
 
Inflammatory cytokines cause CNS2 to be methylated in 
Tet2−/− Tregs 
Previously, it was shown that Tet family members including 
Tet1, Tet2 and Tet3 have an essential role in demethylating the 
CpG motifs of the Foxp3 enhancer, CNS2, during the devel-
opment of Tregs and contribute to the stable expression of 
Foxp3 (Yang et al., 2015; Yue et al., 2016). These reports led 
us to question how the established CNS2 demethylation is 
protected in mature Tregs where DNA methyltransferases 
(Dnmts) work actively (Wang et al., 2013) and whether Tet 
proteins might contribute by not only generating but also main-
taining the CNS2 demethylation. To address these issues, the 
CNS2 methylation status of wild type (WT) and Tet2 deficient 
Tregs was investigated using the ovalbumin (OVA) immuniza-
tion model. Tet2 deficient mice (referred to as Tet2−/− mice) 
were generated by crossing floxed Tet2 (Tet2fl/fl) with CD4-Cre 
transgenic mice. The amount of Tet2, but not Tet1 or Tet3, tran-
scripts greatly decreased in the CD4+ T cells (data not shown). 
Tet2−/− mice were further crossed with OT-II transgenic mice 
expressing OVA-specific TCR (OT-II/Tet2−/− mice) for the OVA 
immunization experiments. Next, we isolated CD4+CD25+ 
Tregs from the LNs of the OT-II/WT or OT-II/Tet2−/− mice (Sup-
plementary Fig. S1) and injected them into congenically marked 
WT B6 mice. CNS2 among the three enhancers (CNS1, CNS2, 
and CNS3) of the Foxp3 gene contains 14 CpG motifs, and 12 
CpG motifs in the antisense strands of the DNA were analyzed 
in this study (Fig. 1A). Freshly isolated OT-II/WT and OT-
II/Tet2−/− Tregs, before being injected, had completely demeth-
ylated CpG motifs (Fig. 1B, left). The recipient mice were then 
immunized with OVA emulsified in complete Freund's adjuvant 
(CFA). CD4+Foxp3+ Tregs of donor origin in the draining LNs 
were re-sorted after 7 days and subjected to bisulfite sequenc-
ing to analyze the methylation status of the CpG motifs in the 
Foxp3 CNS2 region (referred to as CNS2 demethylation analy-
sis hereafter). Almost all the CpG motifs in the CNS2 of the 
transferred WT Tregs maintained their demethylated status. In 
contrast, a significant number of CpG motifs became methylat-
ed in the CNS2 of the Tet2−/− Tregs (Fig. 1B, right). Consistent 
with the results of the CNS2 demethylation analysis, the per-
centage of Foxp3-expressing cells of donor origin was reduced 
in the Tet2−/− Tregs (Figs. 1B and 1D). Next, we additionally 
injected sulfinpyrazone or vehicle (DMSO) into the recipient 
mice treated as above (Fig. 1B). Because sulfinpyrazone is an 
inhibitor of sodium dependent vitamin C transporters and can 
prevent vitamin C from entering cells and activating Tet proteins 
(Dickson et al., 2013), we expected that CNS demethylation 
might be reduced more in the Tet2−/− Tregs treated with sul-
finpyrazone simultaneously. The CD4+Foxp3+ Tregs of donor 
origin were re-sorted and subjected to bisulfite sequencing after 
7 days. As expected, a significant number of CpG motifs be-
came methylated in the CNS2 of the Tet2−/− Tregs treated with 
DMSO, and the extent of CNS2 methylation was larger in the 
Tet2−/− Tregs treated with sulfinpyrazone (Fig. 1C). However, 
the expression of Foxp3 in the donor cells did not change sig-
nificantly by the sulfinpyrazone treatment (Fig. 1D). We next 
performed the CNS2 demethylation analysis with Foxp3-Cre  
Tet2fl/fl transgenic mice and found similar results (Supplemen-
tary Fig. S2). Taken together, these findings suggested that 
Foxp3 CNS2 demethylation and the stable expression of Foxp3 
are actively maintained by Tet2 and its activator vitamin C in 
Tregs. 
DNA methylation is known to be caused by Dnmts, which led 
us to check whether Dnmts are involved in the CNS2 re-
methylation of Tet2−/− Tregs. OT-II/Tet2–/– Tregs were adoptively 
transferred into WT congenic mice, which were immunized with 
OVA/CFA and simultaneously treated with sulfinpyrazone, and 
a cohort of recipient mice were additionally injected with 5-
azacytidine, which is a cytosine nucleoside analogue that inhib-
its the function of Dnmts. Interestingly, CNS2 re-methylation 
was inhibited well by the 5-azacytidine treatment (Fig. 1E) sup-
porting the essential role of Dnmts in CNS2 re-methylation 
induced by cognate antigens and inflammation.
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Fig. 1. Tet2 is essential to maintain CNS2
demethylation in Tregs under inflammatory
conditions. (A) A schematic of the first part of
the Foxp3 locus. White boxes indicate untrans-
lated regions. Three CNS elements are shown
in gray, and the locations of 10 individual CpG
motifs within CNS2 are also shown. First CpG
motif is located 4275 bases downstream of the
TSS (transcription start site, +1). (B) FACS-
sorted WT or Tet2−/− OT-II Tregs (CD45.2+)
were injected into congenically marked WT B6
mice (CD45.1+). Recipient mice were immun-
ized with OVA/CFA the next day. CD4+Foxp3+
cells of donor origin were sorted from the drain-
ing LNs for the CNS2 demethylation study.
Sorted cells were subjected to bisulfate se-
quencing for CNS2 analysis (right) and used to
check the expression of Foxp3 (lower). (C-D)
FACS-sorted WT or Tet2−/− OT-II Tregs were
injected into WT B6 mice, which were immun-
ized with OVA/CFA and treated with sulfinpy-
razone (sulfin) or DMSO (vehicle) every day.
CD4+Foxp3+ cells of donor origin were re-
sorted for the CNS2 demethylation assay. The
extent of CNS2 demethylation of the donor
Foxp3+ cells (C) and the percentages of
Foxp3+ cells of donor CD4+ T cells (D) were
statistically analyzed. Bars show the mean 
SEM (n = 6-8, pooled from three independent
experiments). (E) FACS-sorted Tet2−/− OT-II
Tregs were injected into WT B6 mice, which
were immunized with OVA/CFA and additional-
ly treated with sulfinpyrazone (sulfin)  5-
azacytidine (aza-C). Results of the CNS2 de-
methylation analysis from donor Tregs are
shown (left). Results of the statistical analysis
(right) are from a single experiment (n = 2
mice/group, mean  SEM) representative of
two independent experiments. Methylation
status of 12 individual CpG motifs in the anti-
sense strands of Foxp3 CNS2 is shown by
white (demethylation) or black (methylation)
circles. ***P < 0.001; **P < 0.01; *P < 0.05; NS,
not significant. 
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B 
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Foxp3 stability and the suppressive function are impaired 
in Tet2−/− Tregs with methylated CNS2 
The finding that CNS2 demethylation was labile in Tet2–/– Tregs 
was also seen in vitro. To recapitulate the inflammatory milieu, 
Tregs were cultured with anti-CD3 and CD28 mAbs (anti-
CD3/CD28) plus recombinant IL6 (rIL6) because IL6 is ubiqui-
tously found in inflammatory conditions and has been shown to 
be associated with Foxp3 stability in Tregs (Feng et al., 2014). 
About 50% of the cells maintained the expression of Foxp3 in a 
4-day-culture, and the Foxp3+CD25+ cells were re-sorted for 
CNS2 demethylation analysis (Fig. 2A, upper). Like the in vivo 
study, a significant number of CpG motifs were methylated in 
Tet2−/− Tregs cultured in the presence of rIL6 (Fig. 2A, lower) 
implying that the methylation status of Foxp3 CNS2 is dynami-
cally regulated and not fixed. We also performed the same 
experiments with rIL4 and rIL12; however, much less CpG 
motifs were methylated in the Tregs treated with rIL4 or rIL12 
(Supplementary Fig. S3).  
Next, we investigated the effect of CNS2 re-methylation on 
the Foxp3 stability and the suppressive function of the Tregs. 
Foxp3-expressing cells from Tregs treated with rIL6 shown in 
Fig. 2A were re-sorted and cultured with anti-CD3/CD28 plus 
rIL2, and the expression of Foxp3 was analyzed after 3 days. 
Foxp3 was maintained stably in all the Tregs except for the 
Tet2–/– Tregs pre-treated with rIL6 (Fig. 2B), which was con-
sistent with the results obtained in the CNS2 demethylation 
study. Next, we did an in vitro suppression test to check the 
suppressive function of the corresponding Tregs. Cell division 
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Fig. 2. The functions of Tregs is impaired by
CNS2 re-methylation. (A) FACS-sorted WT or
Tet2−/− Tregs were cultured with anti-
CD3/CD28  rIL6 for 4 days. CD4+Foxp3+ cells
were re-sorted and used for the CNS2 de-
methylation study. Results of statistical analysis
(right) are from a single experiment (n = 2-3
samples/group, mean  SEM) representative of
three independent experiments. (B) Foxp3
(GFP)-expressing Tregs isolated from (A) were
cultured in the presence of anti-CD3/CD28 +
rIL2 (200 ng/ml) and subjected to FACS analy-
sis after 3 days. The frequency of Foxp3+ cells
was statistically analyzed on the right side (n =
5-6, pooled from two independent experi-
ments). (C) Cell division dye (cell trace violet)-
labeled responder cells were cultured in the
presence of various Tregs sorted from (A). The
levels of the cell division dye were checked
after 3 days. Data are representative of three
independent experiments. Methylation status of
individual CpG motifs is shown by white (de-
methylation) or black (methylation) circles.
Numbers in the indicated area in the FACS
plots refer to the percentage of each subset.
***P < 0.001; *P < 0.05; NS, not significant. 
A 
 
 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
 
C 
 
 
 
 
 
 
 
 
 
 
dye (cell trace violet)-labeled CD4+ responder cells were cocul-
tured with antigen presenting cells, Tregs, and anti-CD3 mAbs, 
and the extent of proliferation of the responders was estimated 
with flow cytometry. Tet2–/– Tregs pre-treated with rIL6 showed 
inferior suppressive activity compared to other Tregs (Fig. 2C) 
indicating that the methylation status of the CpG motifs in the 
Foxp3 CNS2 region is closely related with the Foxp3 expres-
sion and suppressive activity in Tregs. 
IL2 is an important survival factor for Tregs (Malek, 2008), 
and media supplemented with rIL2 are commonly used to cul-
ture Tregs in vitro. Thus, we also did the CNS2 demethylation 
experiments with WT or Tet2–/– Tregs cultured in the presence 
of anti-CD3/CD28 + rIL6 plus rIL2. Unexpectedly, the CNS2 of 
the Tet2–/– Tregs was normal (Supplementary Fig. S4). These 
preliminary results led us to hypothesize whether IL2 reverses 
the effects of IL6 on CNS2 re-methylation. 
 
IL2 prevents CNS2 methylation in a Tet-dependent manner 
Because IL2 could be produced by CD4+Foxp3− cells convert-
ed from Tregs and already available even without adding rIL2, 
we started to examine the potential roles of IL2 with a loss-of-
function approach. To neutralize IL2, FACS-sorted WT or 
Tet2−/− Tregs were cultured with anti-IL2 blocking monoclonal 
antibodies (mAbs, clone: S4B6), which reduced the frequency 
of Foxp3+ cells and the expression level of CD25 (Fig. 3A). 
These findings were consistent with our idea that IL2 did al-
ready influence the remaining Tregs. Foxp3+ cells were re-
sorted and subjected to bisulfite sequencing. The CNS2 de-
methylation analysis revealed that most of the CpG motifs be-
came methylated by rIL6 in both the WT and Tet2−/− when IL2 
was neutralized (Figs. 3A and 3B), and they were restored 
(demethylated) in the absence of S4B6 (i.e. in the presence of 
IL2), which occurred less efficiently in the Tet2−/− Tregs. These 
findings suggest that IL2 prevented IL6-mediated CNS2 re-
methylation, albeit partially, in a Tet2 dependent manner. Given 
the potential redundancy between the members of the Tet fami-
ly (Han et al., 2015; Yang et al., 2015), we next investigated 
whether other Tet family members like Tet1 and Tet3 func-
tioned as substitutes for Tet2 downstream of IL2. WT and 
Tet2−/− Tregs were transfected with small interference RNAs 
(siRNAs) targeting Tet1 and Tet3 together and subjected to a 
CNS2 demethylation study. RT-PCR assays revealed that the 
amounts of Tet1 and Tet3 transcripts were specifically reduced 
in the Tet1/Tet3 siRNA-transfected cells (Fig. 3C). Subsequent-
ly, the transfected Tregs were cultured with various doses of 
rIL2. During the cell culture periods, no significant change in the 
cell numbers or expression of Foxp3 was found in the siRNA-
transfected cells (Supplementary Fig. S5). Next, Foxp3+CD25+ 
cells were re-sorted (Supplementary Fig. S6) and subjected to 
bisulfite sequencing. Knockdown of Tet1 and Tet3 significantly 
prevented rIL2 from restoring CNS2 demethylation in the Tet2−/− 
Tregs (Fig. 3D). Furthermore, knockdown of Tet1 and Tet3 
caused CNS2 methylation in the WT Tregs although quite mild-
ly unless rIL2 was added. Taken together, these results clearly 
show that IL2 prevents IL6 from inducing CNS2 re-methylation 
with the Tet members.  
Next, to verify the role of Dmnts in vitro, we cultured WT and 
Tet2−/− Tregs in the presence of 5-azacytidine. Like seen in the in 
vivo results (Fig. 1E), IL6-induced CNS2 re-methylation was abro-
gated by 5-azacytidine treatment in vitro (Supplementary Fig. S7).
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Fig. 3. IL2 inhibits CNS2 methylation in a Tet-
dependent manner. (A) FACS-sorted WT and
Tet2−/− Tregs were cultured under the indicated
conditions and Foxp3+ cells were re-sorted for
the CNS2 demethylation analysis. (B) Results
of the statistical analysis of (A) are shown as
the mean  SEM of 2-3 samples/group (from
one experiment representative of three inde-
pendent experiments). (C) FACS-sorted WT
and Tet2−/− Tregs were transfected with Tet1/
Tet3 siRNAs, and the expression levels of the
indicated gene transcripts were checked by
RT-PCR. (D) WT and Tet2−/− Tregs transfected
with Tet1/Tet3 siRNAs and cultured under the
indicated conditions. Foxp3+CD25+ cells were
re-sorted (Supplementary Fig. S6) and sub-
jected to bisulfate sequencing. Results of the
statistical analysis are shown as the mean 
SEM of 2-3 samples/group (from one experi-
ment representative of two independent exper-
iments). Methylation status of individual CpG
motifs is shown by white (demethylation) or black
(methylation) circles. Numbers in the indicated
area in the FACS plots refer to the percentage of
each subset. ***P < 0.001; *P < 0.05; NS, not
significant. 
A                             B 
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IL2 and vitamin C are required for CNS2 demethylation in 
vivo 
Subsequently, we investigated the role of IL2 on CNS2 de-
methylation with the OVA/CFA immunization model. FACS-
sorted OT-II/WT Tregs were injected into congenically marked 
WT B6 mice, which were treated with anti-IL2 blocking mAbs 
plus sulfinpyrazone. IL2 neutralization treatment downregulated 
CD25 in the donor and host Tregs (Supplementary Fig. S8) but 
did not cause a significant change in the CNS2 demethylation 
status. However, when sulfinpyrazone was treated together, 
more CpG motifs in the CNS2 locus became methylated (Figs. 
4A and 4C), suggesting that vitamin C compensates for the 
loss of IL2 signals in Foxp3 CNS2 demethylation. Next, FACS-
sorted OT-II/Tet2−/− Tregs were injected together with OT-II/WT 
naïve CD4+ T cells at a 1/5 ratio (Treg/naive) into WT B6 mice, 
which were treated with control (rat IgG) or anti-IL2 mAbs. 
CNS2 demethylation analysis revealed that CNS2 in the Tet2−/− 
Tregs became demethylated when injected together with OT-II 
CD4+ T cells, and the effects of co-injection were abrogated by 
anti-IL2 mAbs (Figs. 4B and 4C). Altogether, these in vivo re-
sults were consistent with the in vitro results and imply again 
the essential roles of IL2 and Tet proteins in CNS2 demethyla-
tion.  
 
Tet2 is recruited to the CNS2 locus by IL2 and hinders 
Dnmt1 
It was reported that IL2 is related to the binding of Tet2 to 
Foxp3 enhancers like CNS1 and CNS2 (Yang et al., 2015), 
which led us to hypothesize that IL2 and IL6 would determine 
the methylation status of CNS2 by affecting the binding of Tet2 
or Dnmts, respectively. To test this hypothesis, we examined 
the binding of Tet2 and Dnmt1 by chromatin immunoprecipita-
tion followed by quantitative PCR (ChIP-qPCR) and compared 
their relative enrichments. Because it was recently proposed 
that both Dnmt1 and Dnmt3 are responsible together for CpG 
methylation of nascent and hemi-methylated DNA (Jeltsch and 
Jurkowska, 2014) and Dnmt1 is essential for Tregs (Josefowicz 
et al., 2009; Wang et al., 2013), Dnmt1 was selected in this 
experiment. FACS-sorted WT and Tet2−/− Tregs were cultured 
in the presence of anti-CD3/CD28 plus rIL6  rIL2 for 3 days 
and used for the ChIP-qPCR analysis. Notably, Tet2 and 
Dnmt1 bound to the CNS2 locus in a mutually exclusive man-
ner, which suggested that Tet2 and Dnmt1 might interfere with 
each other’s binding to the same locus (Fig. 5). The binding of 
Tet2 to CNS2 was changed by rIL6 and rIL2: it was high in the 
‘without cytokine treatment’ condition, decreased after the rIL6 
treatment, and restored when treated with both rIL6 and rIL2. 
Dnmt1 also bound to CNS2 but in the opposite way. Further-
more, Tet2 deficiency led to an increase in the Dnmt1 occu-
pancy on the CNS2 locus, suggesting that Dnmt1 binding to 
CNS2 is inhibited by Tet2 recruited by IL2. In contrast, the bind-
ing of Tet2 to the promoter region was not changed by IL6 or 
IL2, and the binding of Dnmt1 was not detected in the promoter 
region. No signal was detected in DNAs immunoprecipitated by 
the isotype control Abs (data not shown). Altogether, these 
results imply that IL2 helped Tet2 to bind to CNS2, which sub-
sequently interfered with the binding of Dnmt1 and eventually 
prevented Dnmts from inducing CNS2 methylation. However, it 
is also possible that Tet2 inhibits CNS2 methylation by actively 
removing the methyl-group that Dnmts had added to the CpG 
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Fig. 4. IL2 and vitamin C are required to pre-
vent CNS2 re-methylation in vivo. (A-B) OT-
II/WT Tregs only (A) or OT-II/Tet2−/− Tregs plus
naïve OT-II T cells (B) were injected into WT
mice, which were immunized with OVA/CFA
and treated as indicated. CD4+Foxp3+ cells of
donor origin were re-sorted and used for the
CNS2 demethylation assay. (C) Statistical
analysis of the above CNS2 demethylation
results (A, B) is shown as the mean  SEM of
2-3 recipient mice/group (from one experiment
representative of two independent experi-
ments). Methylation status of individual CpG
motifs is shown by white (demethylation) or
black (methylation) circles. Numbers in the
indicated area in the FACS plots refer to the
percentage of each subset. ***P < 0.001; **P <
0.01; NS, not significant. 
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Fig. 5. Tet2 is recruited to CNS2 and inhibits the binding of Dnmt1. ChIP-qPCR of Tet2 and Dnmt1 at the Foxp3 promoter and CNS2 locus. 
FACS-sorted WT and Tet2−/− Tregs were cultured in the presence of anti-CD3/CD28 plus rIL6  rIL2, and used for the ChIP analysis. Subse-
quent qPCR was done on DNA precipitated by anti-Tet2 or anti-Dnmt1 Abs (mean  SEM of duplicates, from one experiment representative of 
three independent experiments). **P < 0.01; *P < 0.05; NS, not significant; ND, not detected. 
 
 
 
motifs of CNS2. To evaluate whether the enzymatic activity of 
Tet2 is required to oppose the activity of Dnmts, we analyzed 
the CNS2 demethylation of Tet2−/− Tregs transfected with plas-
mids encoding WT or catalytically inactive (H  D) mutant Tet2 
(Ko et al., 2010). 
The Tet2−/− Tregs were co-transfected with WT or mutant 
Tet2 plasmids (myc-tagged) together with siRNAs targeting Tet1 
and Tet3 to investigate the mechanism of action of Tet2 alone. 
About 40% of the transfected cells expressed Tet2 proteins 4 h 
after transfection, and the amounts of Tet2 transcripts produced 
by the introduced plasmids were similar to each other (Fig. 6A). 
Then, we cultured the transfected cells under the indicated 
conditions and isolated Tregs co-expressing the Foxp3 and 
myc epitopes. CNS2 demethylation analysis revealed that all 
the CpG motifs were demethylated in both the vector- and Tet2 
(both WT and mutant)-transfected Tregs unless rIL6 was added. 
However, treatment with rIL6  rIL2 induced CNS2 methylation 
differentially. Like shown previously (Fig. 3D), a significant 
number of CpG motifs in the Tet2−/− Tregs, in which the Tet1/ 
Tet3 was knock downed, were methylated after rIL6 treatment, 
which was not restored by rIL2. However, the CpG motifs in the 
Tregs transfected with the WT Tet2 plasmids were much less 
methylated by rIL6 and almost completely demethylated by the 
addition of rIL6 + rIL2. Interestingly, the demethylation status of 
the Tet2 mutant Tregs was in between (Fig. 6B) indicating that 
Tet2 prevents CNS2 re-methylation under inflammatory condi-
tions by both the DNA demethylase activity and by antagoniz-
ing the binding of Dnmts to CNS2. These results raised a ques-
tion whether CNS2 demethylation would be restored in Tregs 
simply by enhancing the DNA demethylase activity of the Tet 
enzymes. To address this issue, FACS-sorted WT and Tet2−/− 
Tregs were cultured in the presence of anti-CD3/CD28 + rIL6 + 
S6B6 to induce CNS2 methylation, and vitamin C (10 g/ml), a 
Tet agonist, was added only to a test group. Notably, vitamin C 
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Fig. 6. DNA demethylase activity of Tet2 is required to maintain CNS2 demethylation. (A) FACS-sorted Tet2−/− Tregs were co-transfected with 
plasmids encoding WT or mutant Tet2 (myc-tagged) together with siRNAs targeting Tet1 and Tet3. The expressions of Foxp3 and introduced 
Tet2 (myc) were checked by FACS (left, FACS plots). The expression levels of Tet1, Tet2, and Tet3 transcripts are also shown on the right 
side (mean  SEM of duplicates). Tet2 primers cannot distinguish the endogenous and introduced Tet2 transcripts (WT, mutant). (B) Tet2−/− 
Tregs transfected with vector or Tet2 plasmids were cultured under the indicated conditions, and Foxp3+Myc(Tet2)+ cells were re-sorted for 
CNS2 demethylation. Results of the statistical analysis on CNS2 demethylation are shown (lower) as the mean  SEM of 2 samples/group 
(from one experiment representative of two independent experiments). (C) FACS-sorted WT and Tet2−/− Tregs were cultured under the indi-
cated conditions, and Foxp3+ cells were re-sorted for CNS2 demethylation analysis. Results of the statistical analysis (right) are shown as the 
mean  SEM of 2-3 samples/group (from one experiment representative of two independent experiments). Methylation status of individual 
CpG motifs is shown by white (demethylation) or black (methylation) circles. Numbers in the indicated area in the FACS plots refer to the per-
centage of each subset. ***P < 0.001; **P < 0.01; *P < 0.05; NS, not significant. 
 
 
 
reversed the effect of IL6 and S4B6 in a Tet2 dependent man-
ner (Fig. 6C), supporting the idea that the DNA demethylase 
activity of Tets contributes to maintaining CNS2 demethylation 
in Tregs. 
Here, we showed that demethylation of the CpG motifs in the 
Foxp3 CNS2 region is determined by the competition between 
the DNA modifying enzymes Dnmts and Tets which have op-
posite functions. Dnmt1 was recruited to the CNS2 locus by the 
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inflammatory cytokine IL6 (Fig. 5) and methylated the CpG 
motifs (Fig. 2). In contrast, the methylation activity of Dnmt1 
was abrogated by Tet2 recruited to CNS2 by IL2 (Fig. 5). These 
findings suggest that IL2-Tet2 and IL6-Dnmt1 compete for the 
same binding sites in the CNS2 locus as STAT3 and STAT5 do 
in the IL17 locus (Yang et al., 2011) and Tet2 inhibits Dnmt1 
through the occupation of CNS2. Furthermore, the enzymatic 
activity of Tet2 also contributed to CNS2 demethylation. While 
the demethylation status of CNS2 was restored completely in 
Tet2−/− Tregs transfected with WT Tet2 plasmids, catalytically 
inactive Tet2 (H  D mutant) plasmids showed only partial ef-
fects (Fig. 6B). Consistent with this result, CNS2 re-methylation 
induced in Tregs treated with rIL6 and S4B6 was prevented by 
vitamin C in a Tet2 dependent manner (Fig. 6C). These find-
ings altogether indicate that the demethylation status of CNS2 
is regulated at multiple levels, and Foxp3 expression could be 
maintained consistently unless the activity of Tet proteins is 
reduced significantly. Indeed, Tet2−/− Tregs with methylated 
CNS2 lost Foxp3 expression significantly, which led to the im-
pairment of suppressive functions (Fig. 2C), suggesting that 
CNS2 demethylation is closely related with the Foxp3 expres-
sion and suppressive activity in Tregs. 
In conclusion, our study showed that the methylation status 
of the Foxp3 CNS2 locus is dynamically regulated by a balance 
between two DNA modifying enzymes Dnmts and Tets and 
related cytokines, which influences the stability of Foxp3 ex-
pression in Tregs. 
 
Note: Supplementary information is available on the Molecules 
and Cells website (www.molcells.org). 
 
ACKNOWLEDGMENTS 
We thank Hyun-Ah Lee (Central laboratory Kangwon National 
University, Korea) for cell sorting and Divya Chandrasekharan 
Nair for genotyping. This work was supported by the National 
Research Foundation of Korea (NRF-2013R1A1A2059821) 
and Hallym University (HRF-201601-017). 
 
REFERENCES 
 
Burzyn, D., Kuswanto, W., Kolodin, D., Shadrach, J.L., Cerletti, M., 
Jang, Y., Sefik, E., Tan, T.G., Wagers, A.J., Benoist, C., et al. 
(2013). A special population of regulatory T cells potentiates 
muscle repair. Cell 155, 1282-1295. 
Campbell, D.J., and Koch, M.A. (2011). Phenotypical and functional 
specialization of FOXP3+ regulatory T cells. Nat. Rev. Immunol. 
11, 119-130. 
Chaudhry, A., Rudra, D., Treuting, P., Samstein, R.M., Liang, Y., 
Kas, A., and Rudensky, A.Y. (2009). CD4+ regulatory T cells 
control TH17 responses in a Stat3-dependent manner. Science 
326, 986-991. 
Chung, Y., Tanaka, S., Chu, F., Nurieva, R.I., Martinez, G.J., Rawal, 
S., Wang, Y.H., Lim, H., Reynolds, J.M., Zhou, X.H., et al. (2011). 
Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress 
germinal center reactions. Nat. Med. 17, 983-988. 
Cipolletta, D., Feuerer, M., Li, A., Kamei, N., Lee, J., Shoelson, S.E., 
Benoist, C., and Mathis, D. (2012). PPAR-gamma is a major 
driver of the accumulation and phenotype of adipose tissue Treg 
cells. Nature 486, 549-553. 
Dickson, K.M., Gustafson, C.B., Young, J.I., Zuchner, S., and Wang, 
G. (2013). Ascorbate-induced generation of 5-
hydroxymethylcytosine is unaffected by varying levels of iron and 
2-oxoglutarate. Biochem. Biophys. Res. Commun. 439, 522-527. 
Feng, Y., Arvey, A., Chinen, T., van der Veeken, J., Gasteiger, G., 
and Rudensky, A.Y. (2014). Control of the inheritance of 
regulatory T cell identity by a cis element in the Foxp3 locus. Cell 
158, 749-763. 
Floess, S., Freyer, J., Siewert, C., Baron, U., Olek, S., Polansky, J., 
Schlawe, K., Chang, H.D., Bopp, T., Schmitt, E., et al. (2007). 
Epigenetic control of the foxp3 locus in regulatory T cells. PLoS 
Biol. 5, e38. 
Fontenot, J.D., Gavin, M.A., and Rudensky, A.Y. (2003). Foxp3 
programs the development and function of CD4+CD25+ 
regulatory T cells. Nat. Immunol. 4, 330-336. 
Han, J.A., An, J., and Ko, M. (2015). Functions of TET proteins in 
hematopoietic transformation. Mol. Cells 38, 925-935. 
Hansmann, L., Schmidl, C., Boeld, T.J., Andreesen, R., Hoffmann, 
P., Rehli, M., and Edinger, M. (2010). Isolation of intact genomic 
DNA from FOXP3-sorted human regulatory T cells for epigenetic 
analyses. Eur. J. Immunol. 40, 1510-1512. 
Hori, S., Nomura, T., and Sakaguchi, S. (2003). Control of 
regulatory T cell development by the transcription factor Foxp3. 
Science 299, 1057-1061. 
Huehn, J., and Beyer, M. (2015). Epigenetic and transcriptional 
control of Foxp3+ regulatory T cells. Semin. Immunol. 27, 10-18. 
Huehn, J., Polansky, J.K., and Hamann, A. (2009). Epigenetic 
control of FOXP3 expression: the key to a stable regulatory T-cell 
lineage? Nat. Rev. Immunol. 9, 83-89. 
Jeltsch, A., and Jurkowska, R.Z. (2014). New concepts in DNA 
methylation. Trends Biochem. Sci. 39, 310-318. 
Josefowicz, S.Z., Wilson, C.B., and Rudensky, A.Y. (2009). Cutting 
edge: TCR stimulation is sufficient for induction of Foxp3 
expression in the absence of DNA methyltransferase 1. J. 
Immunol. 182, 6648-6652. 
Kim, H.P., and Leonard, W.J. (2007). CREB/ATF-dependent T cell 
receptor-induced FoxP3 gene expression: a role for DNA 
methylation. J. Exp. Med. 204, 1543-1551. 
Kim, K.Y., Lee, G., Yoon, M., Cho, E.H., Park, C.S., and Kim, M.G. 
(2015). Expression analyses revealed thymic stromal co-
transporter/Slc46A2 is in stem cell populations and is a putative 
tumor suppressor. Mol. Cells 38, 548-561. 
Ko, M., Huang, Y., Jankowska, A.M., Pape, U.J., Tahiliani, M., 
Bandukwala, H.S., An, J., Lamperti, E.D., Koh, K.P., Ganetzky, 
R., et al. (2010). Impaired hydroxylation of 5-methylcytosine in 
myeloid cancers with mutant TET2. Nature 468, 839-843. 
Koch, M.A., Tucker-Heard, G., Perdue, N.R., Killebrew, J.R., Urdahl, 
K.B., and Campbell, D.J. (2009). The transcription factor T-bet 
controls regulatory T cell homeostasis and function during type 1 
inflammation. Nat. Immunol. 10, 595-602. 
Li, X., Liang, Y., LeBlanc, M., Benner, C., and Zheng, Y. (2014). 
Function of a Foxp3 cis-element in protecting regulatory T cell 
identity. Cell 158, 734-748. 
Linterman, M.A., Pierson, W., Lee, S.K., Kallies, A., Kawamoto, S., 
Rayner, T.F., Srivastava, M., Divekar, D.P., Beaton, L., Hogan, 
J.J., et al. (2011). Foxp3+ follicular regulatory T cells control the 
germinal center response. Nat. Med. 17, 975-982. 
Malek, T.R. (2008). The biology of interleukin-2. Annu. Rev. 
Immunol. 26, 453-479. 
Mantei, A., Rutz, S., Janke, M., Kirchhoff, D., Jung, U., Patzel, V., 
Vogel, U., Rudel, T., Andreou, I., Weber, M., et al. (2008). siRNA 
stabilization prolongs gene knockdown in primary T lymphocytes. 
Eur. J. Immunol. 38, 2616-2625. 
Miyao, T., Floess, S., Setoguchi, R., Luche, H., Fehling, H.J., 
Waldmann, H., Huehn, J., and Hori, S. (2012). Plasticity of 
Foxp3(+) T cells reflects promiscuous Foxp3 expression in 
conventional T cells but not reprogramming of regulatory T cells. 
Immunity 36, 262-275. 
Moran-Crusio, K., Reavie, L., Shih, A., Abdel-Wahab, O., Ndiaye-
Lobry, D., Lobry, C., Figueroa, M.E., Vasanthakumar, A., Patel, 
J., Zhao, X., et al. (2011). Tet2 loss leads to increased 
hematopoietic stem cell self-renewal and myeloid transformation. 
Cancer Cell 20, 11-24. 
Ohkura, N., Hamaguchi, M., Morikawa, H., Sugimura, K., Tanaka, 
A., Ito, Y., Osaki, M., Tanaka, Y., Yamashita, R., Nakano, N., et 
al. (2012). T cell receptor stimulation-induced epigenetic changes 
and Foxp3 expression are independent and complementary 
events required for Treg cell development. Immunity 37, 785-799. 
Ohnmacht, C., Park, J.H., Cording, S., Wing, J.B., Atarashi, K., 
Obata, Y., Gaboriau-Routhiau, V., Marques, R., Dulauroy, S., 
Fedoseeva, M., et al. (2015). MUCOSAL IMMUNOLOGY. The 
microbiota regulates type 2 immunity through RORgammat(+) T 
cells. Science 349, 989-993. 
Piper, C., Pesenacker, A.M., Bending, D., Thirugnanabalan, B., 
Varsani, H., Wedderburn, L.R., and Nistala, K. (2014). T cell 
expression of granulocyte-macrophage colony-stimulating factor 
How Demethylation of Foxp3 Enhancer Is Maintained in Tregs 
Varun Sasidharan Nair et al. 
 
 
http://molcells.org  Mol. Cells  897 
 
 
in juvenile arthritis is contingent upon Th17 plasticity. Arthritis 
Rheumatol. 66, 1955-1960. 
Polansky, J.K., Kretschmer, K., Freyer, J., Floess, S., Garbe, A., 
Baron, U., Olek, S., Hamann, A., von Boehmer, H., and Huehn, J. 
(2008). DNA methylation controls Foxp3 gene expression. Eur. J. 
Immunol. 38, 1654-1663. 
Sakaguchi, S., Vignali, D.A., Rudensky, A.Y., Niec, R.E., and 
Waldmann, H. (2013). The plasticity and stability of regulatory T 
cells. Nat. Rev. Immunol. 13, 461-467. 
Sasidharan Nair, V., Song, M.H., and Oh, K.I. (2016). Vitamin C 
Facilitates Demethylation of the Foxp3 Enhancer in a Tet-
Dependent Manner. J. Immunol. 196, 2119-2131. 
Sefik, E., Geva-Zatorsky, N., Oh, S., Konnikova, L., Zemmour, D., 
McGuire, A.M., Burzyn, D., Ortiz-Lopez, A., Lobera, M., Yang, J., 
et al. (2015). MUCOSAL IMMUNOLOGY. Individual intestinal 
symbionts induce a distinct population of RORgamma(+) 
regulatory T cells. Science 349, 993-997. 
Toker, A., Engelbert, D., Garg, G., Polansky, J.K., Floess, S., Miyao, 
T., Baron, U., Duber, S., Geffers, R., Giehr, P., et al. (2013). 
Active demethylation of the Foxp3 locus leads to the generation 
of stable regulatory T cells within the thymus. J. Immunol. 190, 
3180-3188. 
Wang, Y., Su, M.A., and Wan, Y.Y. (2011). An essential role of the 
transcription factor GATA-3 for the function of regulatory T cells. 
Immunity 35, 337-348. 
Wang, L., Liu, Y., Beier, U.H., Han, R., Bhatti, T.R., Akimova, T., 
and Hancock, W.W. (2013). Foxp3+ T-regulatory cells require 
DNA methyltransferase 1 expression to prevent development of 
lethal autoimmunity. Blood 121, 3631-3639. 
Wieczorek, G., Asemissen, A., Model, F., Turbachova, I., Floess, S., 
Liebenberg, V., Baron, U., Stauch, D., Kotsch, K., Pratschke, J., 
et al. (2009). Quantitative DNA methylation analysis of FOXP3 as 
a new method for counting regulatory T cells in peripheral blood 
and solid tissue. Cancer Res. 69, 599-608. 
Yang, X.P., Ghoreschi, K., Steward-Tharp, S.M., Rodriguez-
Canales, J., Zhu, J., Grainger, J.R., Hirahara, K., Sun, H.W., Wei, 
L., Vahedi, G., et al. (2011). Opposing regulation of the locus 
encoding IL-17 through direct, reciprocal actions of STAT3 and 
STAT5. Nat. Immunol. 12, 247-254. 
Yang, R., Qu, C., Zhou, Y., Konkel, J.E., Shi, S., Liu, Y., Chen, C., 
Liu, S., Liu, D., Chen, Y., et al. (2015). Hydrogen Sulfide 
Promotes Tet1- and Tet2-Mediated Foxp3 Demethylation to 
Drive Regulatory T Cell Differentiation and Maintain Immune 
Homeostasis. Immunity 43, 251-263. 
Yue, X., Trifari, S., Aijo, T., Tsagaratou, A., Pastor, W.A., Zepeda-
Martinez, J.A., Lio, C.W., Li, X., Huang, Y., Vijayanand, P., et al. 
(2016). Control of Foxp3 stability through modulation of TET 
activity. J. Exp. Med. 213, 377-397. 
Zheng, Y., Josefowicz, S., Chaudhry, A., Peng, X.P., Forbush, K., 
and Rudensky, A.Y. (2010). Role of conserved non-coding DNA 
elements in the Foxp3 gene in regulatory T-cell fate. Nature 463, 
808-812.
 
